“…When choosing the latter, we were guided by the following reasons: (i) the ability of the acylacetylenes to generate chalcone upon adding protogenic (OH or NH) functions to the triple bond; (ii) potential biological activity of the aromatic (aryl) or heteroaromatic (pyrrolyl, furyl, thienyl) substituents; (iii) synthetically suitable balance between high reactivity and stability (convenience to be handled). The merging of biological active chalcone [ [30] , [31] , [32] ] and quinoline [ [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] ] structures in a one molecule could result in a synergetic effect and extension of the scope of their pharmaceutically important properties. The acetylenic ketone with branched acetal substituents at the triple bond 2i , benzoyloxysecbutylbenzoylacetylene, was specially synthesized to provide additional possibilities for further functionalization (in particular, after deprotection of the hydroxyl group) of adducts as well as to evaluation steric effect of the reaction.…”